XIOMARA DORREJO: Open Payments
NPI 1396253290 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 13 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $172 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $256 |
| Janssen Biotech, Inc. | 3 | $88 |
| Exact Sciences Corporation | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: RINVOQ, TREMFYA, Cologuard Collection Kit, ENTYVIO, XIFAXAN.
Industry payments across NY — which companies pay providers there.
